Herbert B Newton
Overview
Explore the profile of Herbert B Newton including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
1337
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Newton H
J Ayurveda Integr Med
. 2024 Aug;
15(4):101013.
PMID: 39181067
Ayurveda is the traditional medicine system of India, and has been in practice for millennia. It is a traditional approach that uses 1000's of different plant preparations in various combinations...
2.
Newton H, Wojkowski J
Curr Treat Options Oncol
. 2024 Feb;
25(3):389-403.
PMID: 38353859
Seizure activity is common in patients with primary and metastatic brain tumors, affecting more than 50% of cases over the course of their disease. Several mechanisms contribute to brain tumor-related...
3.
Casares M, Skinner H, Gireesh E, Wombles C, Schweitzer J, Gwyn P, et al.
J Neurosci Nurs
. 2019 Jun;
51(4):194-197.
PMID: 31180943
N-methyl-D-aspartate receptor (NMDA-R) antibody encephalitis is an immune-mediated disorder characterized by the presence of anti-NMDA antibody in serum and cerebrospinal fluid, with a characteristic combination of psychological and neurological signs...
4.
Wheeler L, Manzanera A, Bell S, Cavaliere R, McGregor J, Grecula J, et al.
Neuro Oncol
. 2016 Feb;
18(8):1137-45.
PMID: 26843484
Background: Despite aggressive standard of care (SOC) treatment, survival of malignant gliomas remains very poor. This Phase II, prospective, matched controlled, multicenter trial was conducted to assess the safety and...
5.
Nabors L, Portnow J, Ammirati M, Baehring J, Brem H, Brown P, et al.
J Natl Compr Canc Netw
. 2015 Oct;
13(10):1191-202.
PMID: 26483059
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Central Nervous System (CNS) Cancers provide interdisciplinary recommendations for managing adult CNS cancers. Primary and metastatic brain tumors are a...
6.
Chowdhary S, Ryken T, Newton H
J Neurooncol
. 2015 Jan;
122(2):367-82.
PMID: 25630625
Carmustine wafers (CW; Gliadel(®) wafers) are approved to treat newly-diagnosed high-grade glioma (HGG) and recurrent glioblastoma. Widespread use has been limited for several reasons, including concern that their use may...
7.
Ahluwalia M, Xie H, Dahiya S, Hashemi-Sadraei N, Schiff D, Fisher P, et al.
J Neurooncol
. 2014 Dec;
122(1):111-9.
PMID: 25534576
Standard initial therapy for patients with pure and mixed anaplastic oligodendrogliomas (AO/MAO) includes chemotherapy and radiation therapy. Anaplastic oligodendrogliomas with 1p/19q co-deletion are more responsive to chemotherapy. There is concern...
8.
Nabors L, Portnow J, Ammirati M, Brem H, Brown P, Butowski N, et al.
J Natl Compr Canc Netw
. 2014 Nov;
12(11):1517-23.
PMID: 25361798
The NCCN Guidelines for Central Nervous System Cancers provide multidisciplinary recommendations for the clinical management of patients with cancers of the central nervous system. These NCCN Guidelines Insights highlight recent...
9.
Bourekas E, Bell S, Ladwig N, Gandhe A, Shilo K, McGregor J, et al.
J Neuropathol Exp Neurol
. 2014 Apr;
73(5):474-6.
PMID: 24709681
No abstract available.
10.
Hoyle J, Jablonski C, Newton H
Neurohospitalist
. 2014 Apr;
4(2):94-101.
PMID: 24707339
Neurosarcoidosis is frequently on the differential diagnosis for neurohospitalists. The diagnosis can be challenging due to the wide variety of clinical presentations as well as the limitations of noninvasive diagnostic...